EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 3.0

Real-World Effectiveness of Triple Extrafine Fixed-Dose Combination with Beclomethasone/Formoterol/Glycopyrronium on Symptoms and Lung Function in COPD: A Systematic Review and Meta-Analysis

Paola Rogliani iD, Gian Marco Manzetti iD, Mario Cazzola iD, Luigino Calzetta iD

International Journal of Chronic Obstructive Pulmonary Disease · 2025-05 · Volume 20 · 1723-1736

DOI: 10.2147/copd.s511334 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2025-05. Verfasst von Paola Rogliani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy. Hauptthemen laut MEDLINE: Adrenergic beta-2 Receptor Agonists, Anti-Inflammatory Agents, Beclomethasone, Formoterol Fumarate. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Chiesi Italia S.p.A..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenergic beta-2 Receptor AgonistsAnti-Inflammatory AgentsBeclomethasoneFormoterol FumarateGlucocorticoidsGlycopyrrolatePulmonary Disease, Chronic ObstructiveAgedFemaleHumansMaleMiddle AgedAdministration, InhalationBronchodilator AgentsDrug CombinationsForced Expiratory VolumeLungMuscarinic AntagonistsObservational Studies as TopicRecovery of FunctionSeverity of Illness IndexTreatment Outcome

Stichwörter der Autor:innen

COPDlung functionmeta-analysisreal-world evidencesymptoms

Substanzen

Adrenergic beta-2 Receptor AgonistsAnti-Inflammatory AgentsBeclomethasoneBronchodilator AgentsDrug CombinationsFormoterol FumarateGlucocorticoidsGlycopyrrolateMuscarinic Antagonists

Autor:innen und Institutionen

  • Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy.
  • Respiratory Disease and Lung Function Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy.

ORCID-Profile: Paola Rogliani, Gian Marco Manzetti, Mario Cazzola, Luigino Calzetta

Förderung

  • Chiesi Italia S.p.A.

Zitieren

APA

Rogliani, P., Manzetti, G. M., Cazzola, M., & Calzetta, L. (2025). Real-World Effectiveness of Triple Extrafine Fixed-Dose Combination with Beclomethasone/Formoterol/Glycopyrronium on Symptoms and Lung Function in COPD: A Systematic Review and Meta-Analysis. International Journal of Chronic Obstructive Pulmonary Disease, Volume 20, 1723-1736. https://doi.org/10.2147/copd.s511334

Vancouver

Rogliani P, Manzetti GM, Cazzola M, Calzetta L. Real-World Effectiveness of Triple Extrafine Fixed-Dose Combination with Beclomethasone/Formoterol/Glycopyrronium on Symptoms and Lung Function in COPD: A Systematic Review and Meta-Analysis. International Journal of Chronic Obstructive Pulmonary Disease. 2025;Volume 20:1723-1736. doi:10.2147/copd.s511334

BibTeX
@article{Rogliani2025,
  author = {Rogliani, Paola and Manzetti, Gian Marco and Cazzola, Mario and Calzetta, Luigino},
  title = {Real-World Effectiveness of Triple Extrafine Fixed-Dose Combination with Beclomethasone/Formoterol/Glycopyrronium on Symptoms and Lung Function in COPD: A Systematic Review and Meta-Analysis},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2025},
  volume = {Volume 20},
  pages = {1723--1736},
  doi = {10.2147/copd.s511334}
}
Kostenlos starten →